THE SIMMUNOME SOLUTION
VIRTUAL DISEASE MODELS
Computational mapping of the compendium of interactions between human physiological systems and disease at a protein-molecule level.
NOVEL DRUG TARGETS
Identifying and validating novel molecules to target against disease based on our in silico models.
IN SILICO SIMULATIONS
Simulation and predictive analyses of potential outcomes derived from targeted clinical interventions
Simmunome is an artificial intelligence-based contract research organization. We develop industry-ready computational models of pathogenesis and immunogenesis of various diseases with a particular focus on oncology and the nervous system. Our models are achieved by annotating cellular interactions at an in-depth, comprehensive molecular level to attain physiological accuracy.
Our technology offers a tool for pre-screening molecules prior to initiating actual costly, time consuming and risky clinical trials. By use of our technology, the research organisation will be able to test hypotheses prior to incurring these costs and risks. A wide array of candidate chemical pathways and drug targets will be narrowed by the user prior to first administration of experimental drug in patients.
In addition to the benefits of being able to model oncological and nervous system disease as well as interventions in a non-animal model, our simulation engine lays the groundwork for potential use across a large number of clinical settings related to the immune system
Our platform features a robust annotation from which the simulation engine is established. Simulations of physiological events and probable endpoints are further supported by real world evidence from existing clinical trials. The Simmunome is also structured to integrate new emerging data to ensure we stay at the forefront of cutting edge research.
211-825 Boulevard Rene-Levesque Est
Montreal, QC H2L0A1
1800 Hadfield Boulevard
Roswell, GA 30075
Stay Up to Date
2017 Simmunome, Incorporated | All Rights Reserved